1. Home
  2. CSTE vs IXHL Comparison

CSTE vs IXHL Comparison

Compare CSTE & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CSTE

Caesarstone Ltd.

N/A

Current Price

$0.82

Market Cap

27.7M

Sector

Industrials

ML Signal

N/A

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

N/A

Current Price

$4.24

Market Cap

97.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
CSTE
IXHL
Founded
1987
2001
Country
Israel
Australia
Employees
N/A
N/A
Industry
Building Materials
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
27.7M
97.6M
IPO Year
2012
2024

Fundamental Metrics

Financial Performance
Metric
CSTE
IXHL
Price
$0.82
$4.24
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
296.9K
4.5M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$12,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.59
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.79
$0.11
52 Week High
$3.35
$5.17

Technical Indicators

Market Signals
Indicator
CSTE
IXHL
Relative Strength Index (RSI) 20.55 85.43
Support Level N/A $0.31
Resistance Level $1.90 $5.17
Average True Range (ATR) 0.21 0.28
MACD -0.10 0.36
Stochastic Oscillator 2.07 81.26

Price Performance

Historical Comparison
CSTE
IXHL

About CSTE Caesarstone Ltd.

Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa).

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Share on Social Networks: